DEA Receives Application for Importation of Controlled Substance by LTS Therapy Systems
March 07, 2025
March 07, 2025
WASHINGTON, March 7 (TNSFR) -- The Drug Enforcement Administration (DEA) has announced that LTS Therapy Systems, LLC has applied for registration as an importer of a Schedule I controlled substance. The company is based in West Saint Paul, Minnesota, seeks authorization to import dimethyltryptamine (DMT) in bulk form for internal research, development, and analytical purposes.
The application does not permit the importation of finished dosage forms for commercial distribution. The . . .
The application does not permit the importation of finished dosage forms for commercial distribution. The . . .